<?xml version="1.0" encoding="UTF-8"?>
<sec id="sec4-ijms-19-00686" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">4. Antineoplastic Properties of Olive Oil Polyphenols and the Mechanism of Action</div>
 <p xmlns="http://www.w3.org/1999/xhtml">Research has shown that some natural plant-derived polyphenols can directly or indirectly prevent cells from the initiation of neoplastic transformation due to xenobiotics and carcinogenic factors, and thus contribute to a lower risk of developing cancer. Carcinogenesis is characterized by a change in the transcriptional activity of many genes, and consequently in the biological function of the proteins that are encoded by those genes. There are many studies pointing out an essential role of polyphenolic compounds as derived from vegetables, fruits, or herbs in the regulation of epigenetic modifications, resulting in the antiproliferative protection [
  <a rid="B61-ijms-19-00686" ref-type="bibr" href="#B61-ijms-19-00686">61</a>]. Mechanisms of anticancer activity of olive oil polyphenols are presented in 
  <a ref-type="fig" rid="ijms-19-00686-f002" href="#ijms-19-00686-f002">Figure 2</a>.
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Researchers reported anticancer properties of olive leaf extract in an animal skin cancer model. The extract caused cancer cell death, starting with early apoptosis and completing by the following necrosis [
  <a rid="B63-ijms-19-00686" ref-type="bibr" href="#B63-ijms-19-00686">63</a>,
  <a rid="B64-ijms-19-00686" ref-type="bibr" href="#B64-ijms-19-00686">64</a>]. Polyphenols from olive leaf extract showed synergistic effects as combined with standard chemotherapeutic agents [
  <a rid="B63-ijms-19-00686" ref-type="bibr" href="#B63-ijms-19-00686">63</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Our studies on polyphenols of olive oil (especially oleuropein and hydroxytyrosol) also confirmed their anticancer potential on proliferation and cell death of number of cancers (
  <span class="italic">osteosarcoma, neuroblastoma</span>, breast cancer). The obtained data indicate as well the plausible synergism between polyphenols of olive oil and standard chemotherapeutics (data not published yet).
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Epidemiological studies show that people of the Mediterranean region have a lower incidence of several cancers when compared to other populations [
  <a rid="B65-ijms-19-00686" ref-type="bibr" href="#B65-ijms-19-00686">65</a>]. The consumption of olive oil is an important factor in the Mediterranean diet, and is generally believed to be beneficial for health [
  <a rid="B66-ijms-19-00686" ref-type="bibr" href="#B66-ijms-19-00686">66</a>]. Olive oil consumption was proven to prevent from colorectal cancer, breast cancer and skin cancer [
  <a rid="B67-ijms-19-00686" ref-type="bibr" href="#B67-ijms-19-00686">67</a>,
  <a rid="B68-ijms-19-00686" ref-type="bibr" href="#B68-ijms-19-00686">68</a>,
  <a rid="B69-ijms-19-00686" ref-type="bibr" href="#B69-ijms-19-00686">69</a>]. Several mechanisms of antitumor activity of virgin olive oil have been determined. Interestingly, olive oil polyphenols were proven to protect biological membranes against oxidative modification and losing structural integrity. Similarly, polyphenolic compounds decreased oxidative damage to cellular DNA effectively decreasing promotion of colon cancer. In addition to that, HT inhibited lipooxygenase, the enzyme responsible for leukotriene synthesis, and thus modulating the inflammatory response. An alteration of the hormonal status was also observed, specifically due to antiestrogenic effects of lignans that are present in virgin olive oil [
  <a rid="B70-ijms-19-00686" ref-type="bibr" href="#B70-ijms-19-00686">70</a>,
  <a rid="B71-ijms-19-00686" ref-type="bibr" href="#B71-ijms-19-00686">71</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">There are pleiotropic effects of olive oil polyphenols, as observed on the molecular level. It seems however that the antioxidant potential of olive oil is the primary factor contributing to protection against cancer [
  <a rid="B72-ijms-19-00686" ref-type="bibr" href="#B72-ijms-19-00686">72</a>,
  <a rid="B73-ijms-19-00686" ref-type="bibr" href="#B73-ijms-19-00686">73</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Olive oil can also protect against carcinogenic agents that are abundant in the environment and food. Again, the most important protection mechanism is alleviation of oxidative stress phenomena. It is worth mentioning that oleic acid being the major fatty acid present in olive oil TAGs is much less susceptible to oxidation than polyunsaturated acids that are abundant in seed oils. High content of antioxidant polyphenols (hydroxytyrosol, oleuropein) makes virgin olive oil relatively stable and resistant to oxidation, and thus minimizing the risk of formation of potentially carcinogenic products of lipid peroxidation upon storage. Moreover, olive oil polyphenols have been reported to induce beneficial epigenetic modifications [
  <a rid="B74-ijms-19-00686" ref-type="bibr" href="#B74-ijms-19-00686">74</a>] and miRNA expression pattern, lowering cancer risk [
  <a rid="B75-ijms-19-00686" ref-type="bibr" href="#B75-ijms-19-00686">75</a>,
  <a rid="B76-ijms-19-00686" ref-type="bibr" href="#B76-ijms-19-00686">76</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">Studies have shown that both oleuropein and hydroxytyrosol, inhibited angiogenesis and specifically endothelial tube formation by HUVEC cells on Matrigel as well as lowered migration in wound healing assays [
  <a rid="B77-ijms-19-00686" ref-type="bibr" href="#B77-ijms-19-00686">77</a>].
 </p>
 <sec id="sec4dot1-ijms-19-00686" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">4.1. Anticancer Activity of Hydroxytyrosol</div>
  <p xmlns="http://www.w3.org/1999/xhtml">Treatment of human colon adenocarcinoma cells with olive oil polyphenols significantly inhibited cell proliferation [
   <a rid="B78-ijms-19-00686" ref-type="bibr" href="#B78-ijms-19-00686">78</a>,
   <a rid="B79-ijms-19-00686" ref-type="bibr" href="#B79-ijms-19-00686">79</a>,
   <a rid="B80-ijms-19-00686" ref-type="bibr" href="#B80-ijms-19-00686">80</a>]. In spite of the relatively low concentrations of hydroxytyrosol in olive oil, polyphenols are in high micromolar concentration range in the colon after gastric hydrolysis and colonic fermentation of secoiridoids that are naturally present in olive oil [
   <a rid="B81-ijms-19-00686" ref-type="bibr" href="#B81-ijms-19-00686">81</a>]. In colon cancer cells HT reduces epidermal growth factor receptor (EGFR) level by promoting its degradation. EGRF is one of the key receptors triggering colon carcinogenesis as it regulates the proliferation, apoptosis, angiogenesis, and invasion of cancer cells [
   <a rid="B8-ijms-19-00686" ref-type="bibr" href="#B8-ijms-19-00686">8</a>,
   <a rid="B82-ijms-19-00686" ref-type="bibr" href="#B82-ijms-19-00686">82</a>]. Moreover, HT was found to be an effective cytotoxic agent in breast cancer cell models. It inhibited cell cycle in the G0/G1 phase by decreasing the level of cyclin D1 [
   <a rid="B8-ijms-19-00686" ref-type="bibr" href="#B8-ijms-19-00686">8</a>,
   <a rid="B62-ijms-19-00686" ref-type="bibr" href="#B62-ijms-19-00686">62</a>].
  </p>
 </sec>
 <sec id="sec4dot2-ijms-19-00686" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">4.2. Oleuropein as Anticancer Agent</div>
  <p xmlns="http://www.w3.org/1999/xhtml">There are numerous studies confirming the anticancer activity of oleuropein, as observed in human cancer cell lines, such as: breast adenocarcinoma (cell line MCF-7, MDA) [
   <a rid="B83-ijms-19-00686" ref-type="bibr" href="#B83-ijms-19-00686">83</a>,
   <a rid="B84-ijms-19-00686" ref-type="bibr" href="#B84-ijms-19-00686">84</a>,
   <a rid="B85-ijms-19-00686" ref-type="bibr" href="#B85-ijms-19-00686">85</a>,
   <a rid="B86-ijms-19-00686" ref-type="bibr" href="#B86-ijms-19-00686">86</a>,
   <a rid="B87-ijms-19-00686" ref-type="bibr" href="#B87-ijms-19-00686">87</a>], melanoma (cell line RPMI 7951) [
   <a rid="B86-ijms-19-00686" ref-type="bibr" href="#B86-ijms-19-00686">86</a>], urinary bladder carcinoma (cell line T-24) [
   <a rid="B86-ijms-19-00686" ref-type="bibr" href="#B86-ijms-19-00686">86</a>], colorectal adenocarcinoma (cell line HT 29, Caco-2, LoVo) [
   <a rid="B86-ijms-19-00686" ref-type="bibr" href="#B86-ijms-19-00686">86</a>,
   <a rid="B88-ijms-19-00686" ref-type="bibr" href="#B88-ijms-19-00686">88</a>,
   <a rid="B89-ijms-19-00686" ref-type="bibr" href="#B89-ijms-19-00686">89</a>], prostate cancer (cell line TF1) [
   <a rid="B87-ijms-19-00686" ref-type="bibr" href="#B87-ijms-19-00686">87</a>], lung carcinoma (cell line A549) [
   <a rid="B90-ijms-19-00686" ref-type="bibr" href="#B90-ijms-19-00686">90</a>], glioblastoma (cell line LN 18), renal cell adenocarcinoma (cell line 786-O) [
   <a rid="B87-ijms-19-00686" ref-type="bibr" href="#B87-ijms-19-00686">87</a>], and glioma (cell line U251, A172) [
   <a rid="B91-ijms-19-00686" ref-type="bibr" href="#B91-ijms-19-00686">91</a>].
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">Oleuropein was found to display antiproliferative, proapoptotic effects [
   <a rid="B92-ijms-19-00686" ref-type="bibr" href="#B92-ijms-19-00686">92</a>], overall anticancer activity [
   <a rid="B93-ijms-19-00686" ref-type="bibr" href="#B93-ijms-19-00686">93</a>], and specifically an ability to decrease cancer cell viability [
   <a rid="B94-ijms-19-00686" ref-type="bibr" href="#B94-ijms-19-00686">94</a>], as well as induction of cancer cell apoptosis [
   <a rid="B95-ijms-19-00686" ref-type="bibr" href="#B95-ijms-19-00686">95</a>,
   <a rid="B96-ijms-19-00686" ref-type="bibr" href="#B96-ijms-19-00686">96</a>,
   <a rid="B97-ijms-19-00686" ref-type="bibr" href="#B97-ijms-19-00686">97</a>,
   <a rid="B98-ijms-19-00686" ref-type="bibr" href="#B98-ijms-19-00686">98</a>]. Oleuropein induces apoptosis in breast cancer cells (MCF-7) via the 
   <span class="italic">p53</span>-dependent pathway and through the regulation of 
   <span class="italic">Bax</span> and 
   <span class="italic">Bcl2</span> genes. Therefore, oleuropein may have a great therapeutic potential for breast cancer treatment [
   <a rid="B99-ijms-19-00686" ref-type="bibr" href="#B99-ijms-19-00686">99</a>]. Interestingly, oleuropein has been reported to inhibit aromatase, a cytochrome P450 enzyme, which is an important pharmacological target in breast cancer therapy [
   <a rid="B100-ijms-19-00686" ref-type="bibr" href="#B100-ijms-19-00686">100</a>]. Moreover, it increases cancer cell sensitivity to trastuzumab (&gt;1000-fold increase) in SKBR3/Tzb100 cell model of acquired resistance [
   <a rid="B62-ijms-19-00686" ref-type="bibr" href="#B62-ijms-19-00686">62</a>]. Studies in animal models have shown that oleuropein administration prevents breast cancer [
   <a rid="B87-ijms-19-00686" ref-type="bibr" href="#B87-ijms-19-00686">87</a>], skin cancer [
   <a rid="B101-ijms-19-00686" ref-type="bibr" href="#B101-ijms-19-00686">101</a>], and various soft tissue cancers [
   <a rid="B86-ijms-19-00686" ref-type="bibr" href="#B86-ijms-19-00686">86</a>]. 
  </p>
  <p xmlns="http://www.w3.org/1999/xhtml">Interestingly, oleuropein showed uroprotective effect against cyclophosphamide-induced hemorrhagic cystitis in a rat model mostly through its antioxidant and anti-inflammatory activities. [
   <a rid="B102-ijms-19-00686" ref-type="bibr" href="#B102-ijms-19-00686">102</a>]. Thus, it can be considered as a new anticancer compound for adjuvant therapy not only targeting different stages of cancer development, but also alleviating certain adverse effects in the course of cancer chemotherapy. With respect to the pronounced antioxidant properties of oleuropein, it protects cells from genetic damage, potentially leading to oncogenesis. Anti-angiogenic properties of oleuropein prevent or at least slow down tumor development [
   <a rid="B86-ijms-19-00686" ref-type="bibr" href="#B86-ijms-19-00686">86</a>].
  </p>
 </sec>
</sec>
